Cross Atlantic Partners

Investment Portfolio

We focus on companies that are well beyond proof-of-principle in their technology, markets and products.

 

Except for exceptional information companies, we do not participate in the first round of investment.

IMPATH, Inc.

ILEX Oncology, Inc.

Gene Logic, Inc.

SunPharm Corporation

NOMOS Corporation

Martek Biosciences Corporation

AirLogix Corporation

Eximias Pharmaceutical Corp.

Galt Associates, Inc.

Confluent Surgical, Inc.

Medivance, Inc.

Acorda Therapeutics, Inc.

Nutrition 21, Inc.

Labcyte, Inc.

GenomeQuest, Inc.

BioMedical Enterprises, Inc.

LifeMed Media, Inc.

Selected Completed

Active